These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17145218)

  • 1. Adiponectin and renal function, and implication as a risk of cardiovascular disease.
    Iwashima Y; Horio T; Kumada M; Suzuki Y; Kihara S; Rakugi H; Kawano Y; Funahashi T; Ogihara T
    Am J Cardiol; 2006 Dec; 98(12):1603-8. PubMed ID: 17145218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
    Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure.
    Wannamethee SG; Whincup PH; Lennon L; Sattar N
    Arch Intern Med; 2007 Jul; 167(14):1510-7. PubMed ID: 17646605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.
    Mitsnefes M; Kartal J; Khoury P; Daniels S
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):46-50. PubMed ID: 17699386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
    Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
    Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin.
    Nishida H; Horio T; Suzuki Y; Iwashima Y; Kamide K; Kangawa K; Kawano Y
    Peptides; 2008 Apr; 29(4):599-605. PubMed ID: 18222566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.
    Hajer GR; van der Graaf Y; Olijhoek JK; Edlinger M; Visseren FL
    Am Heart J; 2007 Oct; 154(4):750.e1-7. PubMed ID: 17893004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
    Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan.
    Kagiyama S; Matsumura K; Ansai T; Soh I; Takata Y; Awano S; Sonoki K; Yoshida A; Takehara T; Iida M
    Hypertens Res; 2008 Nov; 31(11):2053-8. PubMed ID: 19098377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.
    Rashidi A; Sehgal AR; Rahman M; O'Connor AS
    Am J Cardiol; 2008 Dec; 102(12):1668-73. PubMed ID: 19064021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.
    Dhingra R; Sullivan LM; Fox CS; Wang TJ; D'Agostino RB; Gaziano JM; Vasan RS
    Arch Intern Med; 2007 May; 167(9):879-85. PubMed ID: 17502528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.
    von Eynatten M; Hamann A; Twardella D; Nawroth PP; Brenner H; Rothenbacher D
    Eur Heart J; 2008 May; 29(10):1307-15. PubMed ID: 18390868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
    Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
    Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
    Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
    J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
    McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
    Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.